Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 877

1.

Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.

Vale MJ, Jelinek MV, Best JD, Dart AM, Grigg LE, Hare DL, Ho BP, Newman RW, McNeil JJ; COACH Study Group.

Arch Intern Med. 2003 Dec 8-22;163(22):2775-83.

PMID:
14662633
3.

A randomized controlled trial of a public health nurse directed treatment program for rural patients with high blood cholesterol.

Ammerman AS, Keyserling TC, Atwood JR, Hosking JD, Zayed H, Krasny C.

Prev Med. 2003 Mar;36(3):340-51.

PMID:
12634025
4.

Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G; Cardiovascular Health Evaluation to Improve Compliance and Knowledge Among Uninformed Patients (CHECK-UP) Study Group.

Arch Intern Med. 2007 Nov 26;167(21):2296-303.

PMID:
18039987
5.

How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000.

Vale MJ, Jelinek MV, Best JD; COACH study group. Coaching patients on Achieving Cardiovascular Health.

Med J Aust. 2002 Mar 4;176(5):211-5.

PMID:
11999236
6.
7.
8.

A randomized controlled trial of a physician-directed treatment program for low-income patients with high blood cholesterol: the Southeast Cholesterol Project.

Keyserling TC, Ammerman AS, Davis CE, Mok MC, Garrett J, Simpson R Jr.

Arch Fam Med. 1997 Mar-Apr;6(2):135-45.

PMID:
9075448
10.

The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up.

Jelinek M, Vale MJ, Liew D, Grigg L, Dart A, Hare DL, Best JD.

Heart Lung Circ. 2009 Dec;18(6):388-92. doi: 10.1016/j.hlc.2009.06.001. Epub 2009 Aug 3.

PMID:
19648058
11.
12.

Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.

Sdringola S, Nakagawa K, Nakagawa Y, Yusuf SW, Boccalandro F, Mullani N, Haynie M, Hess MJ, Gould KL.

J Am Coll Cardiol. 2003 Jan 15;41(2):263-72.

14.

Achieving cholesterol target in a managed care organization (ACTION) trial.

Straka RJ, Taheri R, Cooper SL, Smith JC.

Pharmacotherapy. 2005 Mar;25(3):360-71.

PMID:
15843283
15.

Changes in cardiovascular risk factors by combined pharmacological and nonpharmacological strategies: the main results of the CELL Study.

Lindholm LH, Ekbom T, Dash C, Isacsson A, Scherstén B.

J Intern Med. 1996 Jul;240(1):13-22.

PMID:
8708586
16.

Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease.

Lichtman JH, Amatruda J, Yaari S, Cheng S, Smith GL, Mattera JA, Roumanis SA, Wang Y, Radford MJ, Krumholz HM.

Am Heart J. 2004 Mar;147(3):522-8.

PMID:
14999204
17.

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.

Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N.

Am J Med. 2004 May 15;116(10):682-92. Review.

PMID:
15121495
18.

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.

Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Daskalopoulou SS, Kakafika AI, Pehlivanidis AN, Bouloukos VI, Langer A; GREACE Study Collaborative Group.

Curr Med Res Opin. 2004 Sep;20(9):1385-92.

PMID:
15383187
19.

One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk.

Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J.

CMAJ. 2007 Oct 9;177(8):859-65.

20.

Supplemental Content

Support Center